JP2012527487A5 - - Google Patents

Download PDF

Info

Publication number
JP2012527487A5
JP2012527487A5 JP2012512188A JP2012512188A JP2012527487A5 JP 2012527487 A5 JP2012527487 A5 JP 2012527487A5 JP 2012512188 A JP2012512188 A JP 2012512188A JP 2012512188 A JP2012512188 A JP 2012512188A JP 2012527487 A5 JP2012527487 A5 JP 2012527487A5
Authority
JP
Japan
Prior art keywords
trifluoromethyl
compound
group
phenyl
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012512188A
Other languages
English (en)
Japanese (ja)
Other versions
JP5583758B2 (ja
JP2012527487A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2010/073105 external-priority patent/WO2010135972A1/zh
Publication of JP2012527487A publication Critical patent/JP2012527487A/ja
Publication of JP2012527487A5 publication Critical patent/JP2012527487A5/ja
Application granted granted Critical
Publication of JP5583758B2 publication Critical patent/JP5583758B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012512188A 2009-05-25 2010-05-24 1−(置換アリール)−5−トリフルオロメチル−2−(1h)ピリドン化合物及びその塩、並びにその製造方法及びその用途 Expired - Fee Related JP5583758B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200910043501.7 2009-05-25
CN200910043501 2009-05-25
PCT/CN2010/073105 WO2010135972A1 (zh) 2009-05-25 2010-05-24 1-(取代芳基)-5-三氟甲基-2-(1h)吡啶酮化合物及其盐的制备方法及其用途

Publications (3)

Publication Number Publication Date
JP2012527487A JP2012527487A (ja) 2012-11-08
JP2012527487A5 true JP2012527487A5 (enExample) 2013-07-11
JP5583758B2 JP5583758B2 (ja) 2014-09-03

Family

ID=43222160

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012512188A Expired - Fee Related JP5583758B2 (ja) 2009-05-25 2010-05-24 1−(置換アリール)−5−トリフルオロメチル−2−(1h)ピリドン化合物及びその塩、並びにその製造方法及びその用途

Country Status (7)

Country Link
US (1) US8426407B2 (enExample)
EP (1) EP2436670B1 (enExample)
JP (1) JP5583758B2 (enExample)
KR (1) KR101522924B1 (enExample)
CN (1) CN102149682B (enExample)
AU (1) AU2010252447B2 (enExample)
WO (1) WO2010135972A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2691379C (en) 2007-06-20 2015-06-09 Auspex Pharmaceuticals, Inc. Substituted n-aryl pyridinones
ES2716008T3 (es) 2012-07-18 2019-06-07 Sunshine Lake Pharma Co Ltd Derivados heterocíclicos nitrogenados y su aplicación en fármacos
CN102786467A (zh) * 2012-08-15 2012-11-21 浙江省医学科学院 一种n-取代芳基吡啶酮化合物及其制备方法和应用
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
US9902712B2 (en) 2013-12-19 2018-02-27 Sunshine Lake Pharma Co., Ltd. Nitrogenous heterocyclic derivatives and their application in drugs
US10233195B2 (en) 2014-04-02 2019-03-19 Intermune, Inc. Anti-fibrotic pyridinones
WO2015171345A1 (en) * 2014-04-30 2015-11-12 Auspex Pharmaceuticals, Inc. N-aryl pyridinones modulators of fibrosis and/or collagen infiltration
CN106466318B (zh) * 2015-08-21 2019-01-01 中南大学 1-杂环取代苄基吡啶酮类化合物在制备治疗糖尿病肾病药物中的应用
CN113476447A (zh) * 2021-07-09 2021-10-08 中南大学 一种美氟尼酮在制备急性肝损伤药物中的应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4052509A (en) 1972-12-18 1977-10-04 Affiliated Medical Research, Inc. Method for reducing serum uric acid levels
US3839346A (en) 1972-12-18 1974-10-01 Affiliated Med Res N-substituted pyridone and general method for preparing pyridones
US4042699A (en) 1972-12-18 1977-08-16 Affiliated Medical Research, Inc. Method for reducing serum glucose levels
GB8523126D0 (en) 1985-09-19 1985-10-23 Ici Plc Aryl pyridones
GB8621217D0 (en) 1986-09-03 1986-10-08 Ici Plc Chemical compounds
GB8825314D0 (en) 1988-10-28 1988-11-30 Ici Plc Chemical compounds
GB9006479D0 (en) 1989-04-17 1990-05-23 Ici Plc Novel compounds
US5518729A (en) 1989-11-22 1996-05-21 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
US5716632A (en) 1989-11-22 1998-02-10 Margolin; Solomon B. Compositions and methods for reparation and prevention of fibrotic lesions
US5310562A (en) 1989-11-22 1994-05-10 Margolin Solomon B Composition and method for reparation and prevention of fibrotic lesions
US5238906A (en) 1990-11-27 1993-08-24 Sumitomo Chemical Company, Limited Pyridone derivatives and use
DE4343528A1 (de) 1993-12-16 1995-06-22 Schering Ag Zweifach heterocyclisch substituierte Benzole und Pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
ES2334990T3 (es) 2002-02-14 2010-03-18 Pharmacia Corporation Piridinonas sustituidas como moduladores de p38 map quinasa.
CN1218942C (zh) * 2002-06-11 2005-09-14 中南大学湘雅医学院 抗纤维化吡啶酮化合物及其生产工艺方法
US7166603B2 (en) 2003-07-23 2007-01-23 Bristol-Myers Squibb Co. Dihydropyrimidone inhibitors of calcium channel function
CA2545813C (en) 2003-11-14 2011-01-04 Shanghai Genomics, Inc. The derivatives of pyridone and use thereof
DE102004027359A1 (de) 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyridin-2-onverbindungen und deren Verwendung
MX2007014114A (es) 2005-05-10 2008-03-14 Intermune Inc Derivados de piridona para modular el sistema de proteina cinasa activada por estres.
CN101237869A (zh) 2005-05-10 2008-08-06 英特芒尼公司 用于调节应激-活化蛋白激酶系统的吡啶酮衍生物
WO2007053610A2 (en) 2005-11-01 2007-05-10 The Regents Of The University Of California Methods of treating atrial fibrillation wtih pirfenidone
EP1960405A2 (en) 2005-11-23 2008-08-27 Intermune, Inc. Method of modulating stress-activated protein kinase system
CN101235030A (zh) * 2007-01-30 2008-08-06 中南大学 1-取代-5-三氟甲基-2-(1h)吡啶酮化合物、制备方法及其用途
US20090118135A1 (en) 2007-06-08 2009-05-07 The Burnham Institute Methods and compounds for regulating apoptosis
CN101371833A (zh) 2007-08-23 2009-02-25 中南大学 1-芳基-2(1h)-吡啶酮类化合物在制备治疗皮肤瘙痒药物中的应用
JP5627574B2 (ja) 2008-06-03 2014-11-19 インターミューン, インコーポレイテッド 炎症性および線維性疾患を治療するための化合物および方法
EP2389227A4 (en) 2009-01-26 2012-08-08 Intermune Inc METHOD FOR THE TREATMENT OF ACUTE MYOCARDINE CARDS AND ASSOCIATED ILLNESSES THEREOF
WO2010135470A1 (en) 2009-05-19 2010-11-25 Intermune, Inc. Pifenidone derivatives for treating bronchial asthma

Similar Documents

Publication Publication Date Title
RU2451675C2 (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА В КАЧЕСТВЕ АГОНИСТОВ β2-АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
HRP20151405T1 (hr) Novi supstituirani kinolinski spojevi kao inhibitori reduktaze s-nitrosoglutationa
JP2007519754A5 (enExample)
JP2012236838A5 (enExample)
JP2018522823A5 (enExample)
JP2013505969A5 (enExample)
JP2013537203A5 (enExample)
JP2011519854A5 (enExample)
JP2017537960A5 (enExample)
JP2007508305A5 (enExample)
JP2017533968A5 (enExample)
JP2015517981A5 (enExample)
RU2007132262A (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
JP2015531773A (ja) スルファモイル−アリールアミド及びb型肝炎の治療のための薬剤としてのその使用
JP2008517945A5 (enExample)
JP2017504635A5 (enExample)
JP2013531074A5 (enExample)
JP2014526500A5 (enExample)
RU2013138834A (ru) N-[3-(5-амино-3,3а,7,7а-тетрагидро-1н-2,4-диокса-6-аза-инден-7-ил)-фенил]-амиды в качестве ингибиторов васе1 и(или) васе2
JP2013542218A5 (enExample)
JP2008514643A5 (enExample)
JP2014500265A5 (enExample)
JP2010501478A5 (enExample)
RU2009117705A (ru) Производные 2-аминокарбонилпиридина
JP2010505940A5 (enExample)